Page last updated: 2024-10-20

pyrazinamide and Hepatic Encephalopathy

pyrazinamide has been researched along with Hepatic Encephalopathy in 5 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)

Research Excerpts

ExcerptRelevanceReference
"A new, precise, and very selective method for increasing the impact and assessment of 3-nitrotyrosine (3-Nty) as a biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy (MHE) disease was developed."7.83Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid -bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy. ( Al-Radadi, NS; Attia, MS, 2016)
"A new, precise, and very selective method for increasing the impact and assessment of 3-nitrotyrosine (3-Nty) as a biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy (MHE) disease was developed."3.83Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid -bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy. ( Al-Radadi, NS; Attia, MS, 2016)
"Four patients presented hepatic encephalopathy."1.29[Severe hepatotoxicity of tuberculostatic agents. Increase in the incidence]. ( Bruguera, M; Mas, A; Moitinho, E; Rodés, J; Salmerón, JM, 1996)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Attia, MS1
Al-Radadi, NS1
Durand, F2
Bernuau, J2
Pessayre, D2
Samuel, D1
Belaiche, J1
Degott, C1
Bismuth, H1
Belghiti, J2
Erlinger, S2
Rueff, B1
Fournier, M1
Moitinho, E1
Salmerón, JM1
Mas, A1
Bruguera, M1
Rodés, J1
Garavelli, PL1

Reviews

1 review available for pyrazinamide and Hepatic Encephalopathy

ArticleYear
[Fulminant hepatitis during the therapy for tuberculous meningitis].
    Recenti progressi in medicina, 1996, Volume: 87, Issue:12

    Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Female; Hepati

1996

Other Studies

4 other studies available for pyrazinamide and Hepatic Encephalopathy

ArticleYear
Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid -bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy.
    Biosensors & bioelectronics, 2016, Dec-15, Volume: 86

    Topics: Adult; Biomarkers; Early Diagnosis; Equipment Design; Equipment Failure Analysis; Female; Hepatic En

2016
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid.
    Hepatology (Baltimore, Md.), 1995, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Isoniazi

1995
Antituberculous therapy and acute liver failure.
    Lancet (London, England), 1995, May-06, Volume: 345, Issue:8958

    Topics: Antitubercular Agents; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Isoniazid; Liver F

1995
[Severe hepatotoxicity of tuberculostatic agents. Increase in the incidence].
    Gastroenterologia y hepatologia, 1996, Volume: 19, Issue:9

    Topics: Acute Disease; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Chemical and Drug Induced

1996